• LAST PRICE
    2.2900
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (1.7778%)
  • Bid / Lots
    2.2500/ 38
  • Ask / Lots
    2.3500/ 1
  • Open / Previous Close
    2.2600 / 2.2500
  • Day Range
    Low 2.2500
    High 2.3100
  • 52 Week Range
    Low 1.9500
    High 4.7250
  • Volume
    12,332
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.25
TimeVolumeTXMD
09:32 ET4562.26
09:43 ET4762.3
09:45 ET5082.2555
09:54 ET1312.2915
10:17 ET2062.2957
10:24 ET1002.25
10:35 ET1002.29
10:48 ET2002.275
10:51 ET2002.3
11:11 ET1672.2603
12:16 ET2172.3
12:21 ET2222.2701
12:43 ET4002.295
12:50 ET2002.3
12:52 ET1002.31
12:59 ET2142.31
01:24 ET5082.27
01:55 ET2812.2601
02:36 ET5002.26
03:05 ET1002.28
03:16 ET1002.28
03:57 ET1002.3
03:59 ET3532.29
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTXMD
TherapeuticsMD Inc
24.2M
-0.6x
---
United StatesLTUS
Lotus Pharmaceuticals Inc
13.5M
0.1x
+42.39%
United StatesCPIX
Cumberland Pharmaceuticals Inc
23.8M
-3.8x
---
United StatesAOXG
Aoxing Pharmaceutical Company Inc
1.8M
-0.3x
---
United StatesTBET
Tibet Pharmaceuticals Inc
10.0
0.0x
---
United StatesAIDA
Aida Pharmaceuticals Inc
5.4K
0.0x
---
As of 2024-03-29

Company Information

TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Contact Information

Headquarters
951 Yamato Road, Suite 220BOCA RATON, FL, United States 33431
Phone
561-961-1900
Fax
---

Executives

Executive Chairman of the Board
Thomas Thompson
Chief Executive Officer
Marlan Walker
Principal Financial Officer, Principal Accounting Officer
Joseph Ziegler
Independent Director
Cooper Collins
Independent Director
Gail Naughton

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$24.2M
Revenue (TTM)
$2.0M
Shares Outstanding
10.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.03
EPS
$-4.11
Book Value
$3.70
P/E Ratio
-0.6x
Price/Sales (TTM)
12.4
Price/Cash Flow (TTM)
---
Operating Margin
3,078.69%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.